Literature DB >> 32436671

Association between functional and structural connectivity of the corticostriatal network in people with schizophrenia and unaffected first-degree relatives.

Peng Li1, Ri-Xing Jing1, Rong-Jiang Zhao1, Le Shi1, Hong-Qiang Sun1, Zengbo Ding1, Xiao Lin1, Lin Lu1, Yong Fan1.   

Abstract

Background: Dysfunction of the corticostriatal network has been implicated in the pathophysiology of schizophrenia, but findings are inconsistent within and across imaging modalities. We used multimodal neuroimaging to analyze functional and structural connectivity in the corticostriatal network in people with schizophrenia and unaffected first-degree relatives.
Methods: We collected resting-state functional magnetic resonance imaging and diffusion tensor imaging scans from people with schizophrenia (n = 47), relatives (n = 30) and controls (n = 49). We compared seed-based functional and structural connectivity across groups within striatal subdivisions defined a priori.
Results: Compared with controls, people with schizophrenia had altered connectivity between the subdivisions and brain regions in the frontal and temporal cortices and thalamus; relatives showed different connectivity between the subdivisions and the right anterior cingulate cortex (ACC) and the left precuneus. Post-hoc t tests revealed that people with schizophrenia had decreased functional connectivity in the ventral loop (ventral striatum-right ACC) and dorsal loop (executive striatum-right ACC and sensorimotor striatum-right ACC), accompanied by decreased structural connectivity; relatives had reduced functional connectivity in the ventral loop and the dorsal loop (right executive striatum-right ACC) and no significant difference in structural connectivity compared with the other groups. Functional connectivity among people with schizophrenia in the bilateral ventral striatum-right ACC was correlated with positive symptom severity. Limitations: The number of relatives included was moderate. Striatal subdivisions were defined based on a relatively low threshold, and structural connectivity was measured based on fractional anisotropy alone.
Conclusion: Our findings provide insight into the role of hypoconnectivity of the ventral corticostriatal system in people with schizophrenia.
© 2020 Joule Inc. or its licensors.

Entities:  

Year:  2020        PMID: 32436671      PMCID: PMC7595738          DOI: 10.1503/jpn.190015

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  84 in total

Review 1.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits.

Authors:  Julie D Henry; John R Crawford
Journal:  Cogn Neuropsychiatry       Date:  2005-01       Impact factor: 1.871

Review 3.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory.

Authors:  Bram B Zandbelt; Mariët van Buuren; René S Kahn; Matthijs Vink
Journal:  Biol Psychiatry       Date:  2011-09-08       Impact factor: 13.382

5.  A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia.

Authors:  Mario Fioravanti; Olimpia Carlone; Barbara Vitale; Maria Elena Cinti; Linda Clare
Journal:  Neuropsychol Rev       Date:  2005-06       Impact factor: 7.444

Review 6.  Intermediate phenotypes and genetic mechanisms of psychiatric disorders.

Authors:  Andreas Meyer-Lindenberg; Daniel R Weinberger
Journal:  Nat Rev Neurosci       Date:  2006-10       Impact factor: 34.870

Review 7.  A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

Authors:  Eleanor H Simpson; Christoph Kellendonk; Eric Kandel
Journal:  Neuron       Date:  2010-03-11       Impact factor: 17.173

8.  Frontal-striatal cognitive deficits in patients with chronic schizophrenia.

Authors:  C Pantelis; T R Barnes; H E Nelson; S Tanner; L Weatherley; A M Owen; T W Robbins
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

Review 9.  Half a century of antipsychotics and still a central role for dopamine D2 receptors.

Authors:  Shitij Kapur; David Mamo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-10       Impact factor: 5.067

10.  Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.

Authors:  Samuel A Barnes; Stephen J Sawiak; Daniele Caprioli; Bianca Jupp; Guido Buonincontri; Adam C Mar; Michael K Harte; Paul C Fletcher; Trevor W Robbins; Jo C Neill; Jeffrey W Dalley
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

View more
  3 in total

1.  Abnormalities in white matter tracts in the fronto-striatal-thalamic circuit are associated with verbal performance in 22q11.2DS.

Authors:  Carina Heller; Saskia Steinmann; James J Levitt; Nikos Makris; Kevin M Antshel; Wanda Fremont; Ioana L Coman; Stefan R Schweinberger; Thomas Weiß; Sylvain Bouix; Marek R Kubicki; Wendy R Kates; Zora Kikinis
Journal:  Schizophr Res       Date:  2020-10-23       Impact factor: 4.939

2.  Tract-specific white matter microstructural alterations in subjects with schizophrenia and unaffected first-degree relatives.

Authors:  Sangma Xie; Junjie Zhuo; Ming Song; Congying Chu; Yue Cui; Yunchun Chen; Huaning Wang; Lihua Li; Tianzi Jiang
Journal:  Brain Imaging Behav       Date:  2022-06-22       Impact factor: 3.224

3.  Limbic links to paranoia: increased resting-state functional connectivity between amygdala, hippocampus and orbitofrontal cortex in schizophrenia patients with paranoia.

Authors:  Sebastian Walther; Stephanie Lefebvre; Frauke Conring; Nicole Gangl; Niluja Nadesalingam; Danai Alexaki; Florian Wüthrich; Maximilian Rüter; Petra V Viher; Andrea Federspiel; Roland Wiest; Katharina Stegmayer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-10-12       Impact factor: 5.760

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.